New shot may ease nerve pain in diabetes
NCT ID NCT01475786
First seen Nov 01, 2025 · Last updated May 16, 2026 · Updated 27 times
Summary
This study tested a new medicine called Engensis (VM202) to see if it safely reduces pain in people with diabetic nerve damage. 104 adults with type 1 or type 2 diabetes and leg pain for at least 6 months took part. Researchers compared the change in average daily pain over 6 months between those who got the drug and those who got a placebo.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PAINFUL DIABETIC NEUROPATHIES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Beth Israel Deaconess
Boston, Massachusetts, 02115, United States
-
Compass Research
Orlando, Florida, 32806, United States
-
Diablo Clinical Research
Walnut Creek, California, 94598, United States
-
East Virginia Medical School Strelitz Diabetes Center
Norfolk, Virginia, 23510, United States
-
Houston Neurocare
Houston, Texas, 77030, United States
-
Mount Sinai Medical Center
New York, New York, 10029, United States
-
Northwestern University
Chicago, Illinois, 60611, United States
-
Palm Beach Neurological Center
Palm Beach Gardens, Florida, 33418, United States
-
Rainier Clinical Research
Seattle, Washington, 98057, United States
-
Sejong General Hospital
Bucheon-si, Sosa-gu, 422-711, South Korea
-
Seoul National University Bundang Hospital
Seongnam, Bundang-gu, 463-707, South Korea
-
The Catholic University of Korea Youido St. Mary's Hospital
Seoul, Yeongdeungpo-gu, 150-713, South Korea
-
The Methodist Hospital
Houston, Texas, 77030, United States
-
The Neurosciences Institute Albany Medical College
Albany, New York, 12208, United States
-
University of Oklahoma Harold Hamm Diabetes Center
Oklahoma City, Oklahoma, 73104, United States
-
University of Utah
Salt Lake City, Utah, 84132, United States
-
Yonsei University College of Medicine Severance Hospital
Seoul, Seodaemun-gu, 120-752, South Korea
Conditions
Explore the condition pages connected to this study.